Beck Olof, Ericsson Magnus
Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden.
Bioanalysis. 2014 Aug;6(17):2229-44. doi: 10.4155/bio.14.192.
The advent of LC combined with MS made it possible to design analytical methods for urine drug testing based on the very simple concept of diluting urine with an internal standard as the sole preparation procedure prior to instrumental analysis. The number of publications using this method design increased after the development of high-efficiency LC based on sub-2 μm particles. The success of this method design for drug testing, doping control and toxicological investigations of urine is now well documented and comprise both screening and confirmation methods. The nondiscriminating nature of this method design makes it even more attractive in combination with high-resolution MS for multicomponent target and general unknown analysis applications.
液相色谱(LC)与质谱(MS)联用技术的出现,使得基于在仪器分析前仅用内标稀释尿液这一非常简单的概念来设计尿液药物检测分析方法成为可能。基于亚2微米颗粒的高效液相色谱技术发展之后,采用这种方法设计的出版物数量有所增加。这种用于尿液药物检测、兴奋剂检测和毒理学调查的方法设计的成功,如今已有充分记录,涵盖了筛查和确证方法。这种方法设计的非歧视性,使其与高分辨率质谱联用,在多组分目标分析和一般未知物分析应用中更具吸引力。